These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19754000)

  • 1. Biological prognostic markers in chronic lymphocytic leukemia.
    Vroblová V; Smolej L; Vrbacký F; Jankovicová K; Hrudková M; Malý J; Krejsek J
    Acta Medica (Hradec Kralove); 2009; 52(1):3-8. PubMed ID: 19754000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
    Xu W; Li JY; Shen QD; Wu YJ; Yu H; Fan L
    Int J Lab Hematol; 2009 Oct; 31(5):552-9. PubMed ID: 18616755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
    Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
    Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
    Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
    Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
    Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia.
    Jain N; Lamanna N
    Curr Oncol Rep; 2009 Sep; 11(5):353-9. PubMed ID: 19679010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
    Mainou-Fowler T; Dignum HM; Proctor SJ; Summerfield GP
    Leuk Lymphoma; 2004 Mar; 45(3):455-62. PubMed ID: 15160906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
    J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ZAP-70 in B-cell chronic lymphocytic leukemia: clinical significance and methods of detection].
    Smolej L; Saudková L; Spacek M; Kozák T
    Vnitr Lek; 2006 Dec; 52(12):1194-9. PubMed ID: 17299914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.
    Morilla A; Gonzalez de Castro D; Del Giudice I; Osuji N; Else M; Morilla R; Brito Babapulle V; Rudenko H; Matutes E; Dearden C; Catovsky D; Morgan GJ
    Leuk Lymphoma; 2008 Nov; 49(11):2108-15. PubMed ID: 19021053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress on prognostic markers of chronic lymphocytic leukemia].
    Mao J; Mao ZR; Zhou R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):250-6. PubMed ID: 20544986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
    Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
    Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
    Weinberg JB; Volkheimer AD; Chen Y; Beasley BE; Jiang N; Lanasa MC; Friedman D; Vaccaro G; Rehder CW; Decastro CM; Rizzieri DA; Diehl LF; Gockerman JP; Moore JO; Goodman BK; Levesque MC
    Am J Hematol; 2007 Dec; 82(12):1063-70. PubMed ID: 17654680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
    Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.